Senti Biosciences, Inc. (SNTI) Financials

SNTI Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 38.2 million 35.7 million
Dec. 31, 2025 51.2 million 45.6 million
Sept. 30, 2025 52.7 million 44.6 million
June 30, 2025 68.5 million 43.9 million

SNTI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -7.5 million 1.3 million
Dec. 31, 2025 -6.9 million 1.4 million
Sept. 30, 2025 -9.4 million 1.6 million
June 30, 2025 -13.3 million 1.5 million

SNTI Net Income

No data available :(

SNTI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 8.9 million 13.3 million -
Dec. 31, 2025 16.4 million 23.6 million 28.9 million
Sept. 30, 2025 12.2 million 25.0 million 30.1 million
June 30, 2025 21.6 million - 31.3 million

SNTI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 31.0 million
Dec. 31, 2025 22.5 million
Sept. 30, 2025 26.2 million
June 30, 2025 26.1 million

SNTI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 5.3 million 6.2 million -
Dec. 31, 2025 - 7.8 million 5.8 million -
Sept. 30, 2025 - 10.5 million 5.8 million -
June 30, 2025 196000 9.8 million 6.8 million -

SNTI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 22000 893000
Sept. 30, 2025 - 904000
June 30, 2025 - 1.5 million

SNTI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SNTI

Price: $0.93

52 week price:
0.77
3.88

Earnings Per Share: -1.46 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 26.3 million

Links: